INSPECS Group (SPEC) H2 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 TU earnings summary
8 Aug, 2025Financial performance
Full-year revenue reached £200.5m, slightly down from £203.3m in 2023, with underlying EBITDA at £17.5m, in line with updated expectations.
H2 2024 revenue grew 5.9% to £97.5m, and gross profit margin improved to 51.4% from 50.9%.
Net debt (excluding leases) reduced by £1.3m to £22.9m, with continued investment in manufacturing capacity.
Operational highlights
US business integration completed and new Vietnam facility fully operational, supporting expanded manufacturing.
Eschenbach Optics division performed strongly, especially in the US and Europe, with new digital low vision aids well received.
European operations gained market share despite a soft market environment.
Strategic initiatives and outlook
Banking facilities refinanced and extended to 2027, expected to reduce interest costs by £0.6m in 2025.
Focus remains on operational efficiencies, cost control, debt reduction, and margin improvement.
2025 objectives include revenue growth and higher EBITDA margins, building on a solid start to the year.
Latest events from INSPECS Group
- Revenue down 7.3%, margins up, net debt reduced, and H2 trading and orders ahead.SPEC
H1 202421 Jan 2026 - Revenue and EBITDA fell, but cost savings, new brands, and order growth support full-year guidance.SPEC
H1 202518 Sep 2025 - 2024 revenue forecast at £197m, with new Vietnam facility to drive 2025 growth.SPEC
Q3 2024 TU8 Aug 2025 - Revenue down 2% but margin and cash flow improved; outlook for 2025 remains positive.SPEC
H2 20248 Aug 2025 - H1 revenue and EBITDA fell, but full-year results are expected to match 2024 after cost savings.SPEC
H1 2025 TU8 Aug 2025